Skip to main content
Equibles
YCBD logo

YCBD · cbdMD, Inc. · Webcasts, Transcripts & Audio

Track YCBD — free

Use YCBD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research YCBD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.45 +0.02 (+3.80%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company’s ability to continue as a going concern is dependent upon its ability to improve profitability and cash flow and the ability to acquire additional funding. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern within twelve months after the date that these financial statements are issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$5.22M
Shares
11.21M
Volume · Oct 5 81.43K Avg daily vol (3M) 436.46K

cbdMD, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for cbdMD, Inc. (YCBD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲2079.2% $10.15M $12.93M '20 Q1 19-12-31 ▲66.8% $9.40M $14.88M '20 Q2 20-04-06 ▲32.9% $10.64M −$8.95M '20 Q3 20-08-04 ▲25.5% $11.80M −$12.51M '21 Q2 21-05-12 ▼0.7% $10.56M $1.54M '21 Q3 21-08-12 ▼24.4% $9.32M −$19.16M '22 Q1 21-12-31 ▼18.6% $8.59M −$31.63M '22 Q3 22-06-30 ▼19.7% $7.86M −$14.63M '22 Q4 22-09-30 ▼35.2% $6.24M −$1.34M '23 Q2 23-03-31 ▼15.5% $5.17M $459,737 '24 Q3 24-06-30 ▼4.9% $5.11M $15,095 '25 Q1 24-12-31 ▲8.5% $4.75M −$480,757 '25 Q2 25-03-31 ▲3.6% $4.72M −$679,968 '25 Q4 25-11-25 LATEST ▲20.6% $5.55M −$1.13M '26 Q3 26-08-13
Earnings call
FY26 · Q3
2026-08-13
cbdMD, Inc. (YCBD) Q3 2026 Earnings Call Transcript
Positive tone Revenue growth and top-line momentum Oasis brand and hemp-derived THC products Regulatory environment and Section 781
Revenue
$5.55M
▲ 20.6% YoY
Gross margin
54.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-11-25
cbdMD, Inc. (YCBD) Q4 2025 Earnings Call Transcript
Positive tone Federal cannabis/hemp executive order Operating loss reduction and financial discipline Oasis beverage brand expansion
Revenue
$4.72M*
▲ 3.6% YoY
Gross margin
58.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q2
2025-03-31
cbdMD, Inc. (YCBD) Q2 2025 Earnings Call Transcript
Confident tone Liquidity and working capital Herbal Oasis THC seltzer Capital structure reset and NYSE compliance
Revenue
$4.75M
▲ 8.5% YoY
Gross margin
62.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-12-31
cbdMD, Inc. (YCBD) Q1 2025 Earnings Call Transcript
Confident tone Liquidity and working capital Product innovation pipeline Oasis social tonic beverage launch
Revenue
$5.11M
▼ 4.9% YoY
Gross margin
66.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-06-30
cbdMD, Inc. (YCBD) Q3 2024 Earnings Call Transcript
Positive tone NYSE American listing compliance Revenue decline and profitability progress Capital structure and balance sheet
Revenue
$5.17M
▼ 15.5% YoY
Diluted EPS
$-1.20
Gross margin
65.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-03-31
cbdMD, Inc. (YCBD) Q2 2023 Earnings Call Transcript
Revenue
$6.24M
▼ 35.2% YoY
Diluted EPS
$-13.92
Gross margin
64.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-09-30
cbdMD, Inc. (YCBD) Q4 2022 Earnings Call Transcript
Revenue
$7.86M*
▼ 19.7% YoY
Gross margin
63.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-06-30
cbdMD, Inc. (YCBD) Q3 2022 Earnings Call Transcript
Revenue
$8.59M
▼ 18.6% YoY
Diluted EPS
$-198.48
▼ 2856.7% YoY
Gross margin
69.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2021-12-31
cbdMD, Inc. (YCBD) Q1 2022 Earnings Call Transcript
Revenue
$9.32M
▼ 24.4% YoY
Diluted EPS
$-126.00
Gross margin
53.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q3
2021-08-12
cbdMD, Inc. (YCBD) Q3 2021 Earnings Call Transcript
Revenue
$10.56M
▼ 0.7% YoY
Diluted EPS
$7.20
Gross margin
68.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-05-12
cbdMD, Inc. (YCBD) Q2 2021 Earnings Call Transcript
Revenue
$11.80M
▲ 25.5% YoY
Diluted EPS
$-86.40
▼ 160% YoY
Gross margin
69.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q3
2020-08-04
cbdMD, Inc. (YCBD) Q3 2020 Earnings Call Transcript
Revenue
$10.64M
▲ 32.9% YoY
Diluted EPS
$0.00
Gross margin
64.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-04-06
cbdMD, Inc. (YCBD) Q2 2020 Earnings Call Transcript
Revenue
$9.40M
▲ 66.8% YoY
Diluted EPS
$144.00
Gross margin
70.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2019-12-31
cbdMD, Inc. (YCBD) Q1 2020 Earnings Call Transcript
Revenue
$10.15M
▲ 2079.2% YoY
Diluted EPS
$162.00
Gross margin
63.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–14 of 14 webcasts
Key facts CIK 1644903 CUSIP 12482W408 Visit website Investor relations